Vanishing bile duct syndrome in human immunodeficiency virus infected adults: A report of two cases

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

657

HTML

5750

Figures (1-1)

175

Tables (1-1)

127

Sum=6709

Jan 7, 2013 (publication date) through May 1, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jan 7, 2013; 19(1): 115-121
Published online Jan 7, 2013. doi: 10.3748/wjg.v19.i1.115

Table 1 Selected medications associated with chronic cholestasis and vanishing bile duct syndrome

Medication class	Medication
Antimicrobials	Penicillins
	Fluroquinolones
	Trimethoprim-sulfamethoxazole
	Azithromycin
	Tetracyclines
	Clindamycin
	Carbapenems
	Itraconazole
	Terbinafine
Antiretrovirals	Nevirapine
Anticonvulsants	Carbamazepine
	Valproic acid
NSAIDS	Ibuprofen
Sex steroids	Testosterone
Antidepressants	Amitriptyline
Antipsychotics	Risperidone
Immunomodulating	Interleukin-2
Anti-lipid Agents	Atorvastatin
	Fenofibrate

NSAIDS: Nonsteroidal antiinflammatory drugs.

Citation: Oppenheimer AP, Koh C, McLaughlin M, Williamson JC, Norton TD, Laudadio J, Heller T, Kleiner DE, High KP, Morse CG. Vanishing bile duct syndrome in human immunodeficiency virus infected adults: A report of two cases. World J Gastroenterol 2013; 19(1): 115-121
URL: https://www.wjgnet.com/1007-9327/full/v19/i1/115.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i1.115